A new drug-eluting stent (DES) that features a second drug, cilostazol, in addition to paclitaxel shows noninferiority to the standard Taxus stent, with angiographic outcomes similar to other DES ...

Cilostazol (Pletal; Otsuka America Pharmaceutical, Inc, Rockville, Maryland) is a new antiplatelet agent that increases the concentration of cAMP within the platelets by selectively blocking ...

March 9, 2010 (San Antonio, Texas) — The phosphodiesterase inhibitor cilostazol is more effective in secondary stroke prevention and has a significantly lower incidence of serious cerebral hemorrhage ...

Dual antiplatelet therapy (DAT) with aspirin and clopidogrel is the standard regimen to achieve rapid platelet inhibition and prevent thrombotic events. Currently, little information is available ...

A recent study demonstrated the safety of cilostazol in patients with mild cognitive impairment (MCI), but did not demonstrate any efficacy in preventing disease progression. However, after ...

Adjunctive cilostazol is noninferior to double-dose clopidogrel in patients undergoing percutaneous coronary intervention (PCI), according to a study published in the September 1, 2013, issue of JACC: ...

People who experience a type of stroke linked with nearly half of all dementias could be treated for the first time by repurposing two cheap and common drugs, a trial shows. Researchers found that ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with a high–thrombosis-risk paclitaxel-eluting stent who were given cilostazol before ...

Cilostazol given prior to a surgical procedure resulted in a safer transition off to dual antiplatelet therapy (DAPT) by reducing the risk the risk of bleeding during the operation in patients with a ...